Psychological distress and circulating inflammatory markers in healthy young adults

Psychological Medicine

Volumn 40, Issue 12, 2010, Pages 2079-2087

  Goldman Mellor, S ^a   Brydon, L ^b   Steptoe, A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coagulation; coronary heart disease; emotional distress; inflammation; psychological factors

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; MENTAL STRESS; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; MALE; REGRESSION ANALYSIS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 78650309504     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291710000267     Document Type: Article

References (50)

1. Barth J, Schumacher M, Herrmann-Lingen C (2004). Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomatic Medicine 66, 802-813.
2. Black P, Garbutt L (2002). Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research 52, 1-23.
3. Carney RM, Freedland KE, Stein PK, Miller GE, Steinmeyer B, Rich MW, Duntley SP (2007). Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. Journal of Psychosomatic Research 62, 463-467.
4. Castell JV, Gómez-Lechón MJ, David M, Fabra R, Trullenque R, Heinrich PC (1990). Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12, 1179-1186.
5. Cook DG, Cappuccio FP, Atkinson RW, Wicks PD, Chitolie A, Nakandakare ER, Sagnella GA, Humphries SE (2001). Ethnic differences in fibrinogen levels: the role of environmental factors and the b-fibrinogen gene. American Journal of Epidemiology 153, 799-806.
6. Craig R, Mindell J (ed.) (2007). Health Survey for England 2006. Volume 3: Methodology and Documentation. The Information Centre: Leeds, UK.
7. Danese A, Moffitt T, Pariante C, Ambler A, Poulton R, Caspi A (2008). Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Archives of General Psychiatry 65, 409-416.
8. Danner M, Kasl S, Abramson J, Vaccarino V (2003). Association between depression and elevated C-reactive protein. Psychosomatic Medicine 65, 347-356.
9. Davidson KW, Schwartz JE, Kirkland SA, Mostofsky E, Fink D, Guernsey D, Shimbo D (2009). Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia Health Survey (NSHS95) Prospective Population Study). American Journal of Cardiology 103, 755-761.
10. Department of Health (2004). Health Survey for England (HSE) 2003. Methodology and documentation report (www.archive2.officialdocuments.co.uk/ document/ deps/doh/survey03/md/md.htm). Accessed 15 June 2008.
11. Doulalas A, Rallidis L, Gialernios T, Moschonas DN, Kougioulis MN, Rizos I, Tselegaridis TS, Kremastinos DT (2006). Association of depressive symptoms with coagulation factors in young healthy individuals. Atherosclerosis 186, 121-125.
12. Elovainio M, Keltikangas-Järvinen L, Pulkki-Raback L, Kivimäki M, Puttonen S, Viikari L, Raitakari O (2006). Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychological Medicine 36, 797-805.
13. Fibrinogen Studies Collaboration (2005). Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. Journal of the American Medical Association 294, 1799-1809.
14. Fibrinogen Studies Collaboration (2007). Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies. American Journal of Epidemiology 166, 867-879.
15. Ford D, Erlinger T (2004). Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 164, 1010-1014.
16. Furukawa TA, Kessler RC, Slade T, Andrews G (2003). The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychological Medicine 33, 357-362.
17. Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, Kumari M, Lowe GD, Rumley A, Marmot MG, Ferrie JE (2008). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychological Medicine 4, 1-11.
18. Goldberg D, Williams P (1988). A User's Guide to the GHQ. NFER-Nelson: Windsor, UK.
19. Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C (1997). The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychological Medicine 27, 191-197.
20. Gorman JM, Sloan RP (2000). Heart rate variability in depressive and anxiety disorders. American Heart Journal 140, 77-83.
21. Grano N, Keltikangas-Jarvinen L, Kouvonen A, Virtanen M, Elovainio M, Vahtera J, Kivimaki M (2007). Impulsivity as a predictor of newly diagnosed depression. Scandinavian Journal of Psychology 48, 173-179.
22. Hayley S, Poulter MO, Merali Z, Anisman H (2005). The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135, 659-678.
23. Hirokawa K, Tsutsumi A, Kayaba K (2008). Psychosocial job characteristics and plasma fibrinogen in Japanese male and female workers: the Jichi Medical School cohort study. Atherosclerosis 198, 468-476.
24. Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71, 171-186.
25. Irwin M, Miller A (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain Behavior and Immunity 21, 374-383.
26. Koenig W (2003). Fibrin(ogen) in cardiovascular disease: an update. Journal of Thrombosis and Haemostasis 89, 601-609.
27. Kubzansky LD, Cole SR, Kawachi I, Vokonas P, Sparrow D (2006). Shared and unique contributions of anger, anxiety, and depression to coronary heart disease: a prospective study in the Normative Aging Study. Annals of Behavioral Medicine 31, 21-29.
28. Kudielka BM, Bellingrath S, von Känel R (2008). Circulating fibrinogen but not d-dimer level is associated with vital exhaustion in school teachers. Stress 11, 250-258.
29. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Räsänen JP, Leinonen M, Meyer-Rochow VB, Timonen M (2006). The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biological Psychiatry 60, 825-830.
30. Matthews KA, Schott LL, Bromberger J, Cyranowski J, Everson-Rose SA, Sowers MF (2007). Associations between depressive symptoms and inflammatory/ hemostatic markers in women during the menopausal transition. Psychosomatic Medicine 69, 124-130.
31. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA (2002). Clinical depression and inflammatory risk markers for coronary heart disease. American Journal of Cardiology 90, 1279-1283.
32. Nabi H, Singh-Manoux A, Shipley M, Gimeno D, Marmot MG, Kivimaki M (2008). Do psychological factors affect inflammation and incident coronary heart disease: The Whitehall II Study. Arteriosclerosis, Thrombosis, and Vascular Biology 28, 1398-1406.
33. Nazmi A, Oliveira IO, Victora CG (2008). Correlates of C-reactive protein levels in young adults: a population-based cohort study of 3827 subjects in Brazil. Brazilian Journal of Medical and Biological Research 41, 357-367.
34. O'Loughlin J, Lambert M, Karp I, McGrath J, Gray-Donald K, Barnett TA, Delvin EE, Levy E, Paradis G (2008). Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents. Nicotine and Tobacco Research 10, 525-532.
35. Pan A, Ye X, Franco OH, Li H, Yu Z, Wang J, Qi Q, Gu W, Pang X, Liu H, Lin X (2008). The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS ONE 3, e1392.
36. Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christodoulou G, Stefanadis C; ATTICA study (2004). Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. European Heart Journal 25, 492-499.
37. Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C (2006). Anxiety in relation to inflammation and coagulation markers, among healthy adults: The ATTICA Study. Atherosclerosis 185, 320-326.
38. Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24-31.
39. Ranjit N, Diez-Roux AV, Shea S, Cushman M, Seeman T, Jackson SA, Ni H (2007). Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Archives of Internal Medicine 167, 174-181.
40. Rugulies R (2002). Depression as a predictor for coronary heart disease: a review and meta-analysis. American Journal of Preventive Medicine 23, 51-61.
41. Schroeder V, Borner U, Gutknecht S, Schmid JP, Saner H, Kohler HP (2007). Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation 14, 782-787.
42. Steptoe A (2006). Depression and the development of coronary heart disease. In Depression and Physical Illness (ed. A. Steptoe), pp. 53-86. Cambridge University Press: Cambridge.
43. Steptoe A, Brydon L (2007). Psychosocial factors and coronary heart disease: the role of psychoneuroimmunological processes. In Psychoneuroimmunology, 4th edn (ed. R. Ader), pp. 945-974. Elsevier: San Diego.
44. Steptoe A, Kunz-Ebrecht SR, Owen N (2003). Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychological Medicine 33, 667-674.
45. Suarez EC (2004). C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosomatic Medicine 66, 684-691.
46. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH (1997). Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 17, 2167-2176.
47. von Känel R, Hepp U, Buddeberg C, Keel M, Mica L, Aschbacher K, Schnyder U (2006). Altered blood coagulation in patients with posttraumatic stress disorder. Psychosomatic Medicine 68, 598-604.
48. von Känel R, Mausbach BT, Kudielka BM, Orth-Gomér K (2008). Relation of morning serum cortisol to prothrombotic activity in women with stable coronary artery disease. Journal of Thrombosis and Thrombolysis 25, 165-172.
49. von Känel R, Mills PJ, Fainman C, Dimsdale JE (2001). Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosomatic Medicine 63, 531-544.
50. Whooley M, Caska C, Hendrickson B, Rourke M, Ho J, Ali S (2007). Depression and inflammation in patients with coronary heart disease : findings from the Heart and Soul Study. Biological Psychiatry 62, 314-320.